Worth Venture Partners, LLC - TRANSCODE THERAPEUTICS INC ownership

TRANSCODE THERAPEUTICS INC's ticker is RNAZ and the CUSIP is 89357L105. A total of 14 filers reported holding TRANSCODE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Worth Venture Partners, LLC ownership history of TRANSCODE THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$357,000
-20.1%
324,1570.0%0.22%
-16.7%
Q2 2022$447,000
-52.1%
324,1570.0%0.26%
-39.0%
Q1 2022$934,000
+24.4%
324,157
+9.7%
0.43%
+15.9%
Q4 2021$751,000
-15.0%
295,540
+0.0%
0.37%
-6.5%
Q3 2021$884,000295,5180.40%
Other shareholders
TRANSCODE THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
AIGH Capital Management LLC 1,289,000$1,418,0000.44%
Worth Venture Partners, LLC 324,157$357,0000.22%
Redmond Asset Management, LLC 90,874$100,0000.04%
ACT CAPITAL MANAGEMENT, LLC 6,500$7,0000.01%
K.J. Harrison & Partners Inc 19,987$22,0000.01%
Shay Capital LLC 15,060$17,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 76,549$84,0000.00%
STATE STREET CORP 21,019$23,0000.00%
BlackRock Inc. 15,334$17,0000.00%
View complete list of TRANSCODE THERAPEUTICS INC shareholders